TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis (2021)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05384-5
PubMed Identifier: 34229728
Publication URI: http://europepmc.org/abstract/MED/34229728
Type: Journal Article/Review
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215